Clinical trials
Completed Phase 3 Adenocarcinoma of Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 2 |
| 2010 | 1 |
| 2013 | 2 |
| 2019 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alliance for Clinical Trials in Oncology | 4 |
| National Cancer Institute (NCI) | 4 |
| Novartis Pharmaceuticals | 2 |
| Celltrion | 1 |
| ECOG-ACRIN Cancer Research Group | 1 |
| Eastern Cooperative Oncology Group | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Japan Multinational Trial Organization | 1 |
| NCIC Clinical Trials Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma of Lung | 21 |
| Carcinoma, Non-Small-Cell Lung | 20 |
| Lung Neoplasms | 15 |
| Adenocarcinoma, Bronchiolo-Alveolar | 7 |
| Fatigue | 1 |
| Nausea | 1 |
| Pain | 1 |
| Vomiting | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.